CAS: 934823-49-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Urelumab REF: TM-T77367CAS: 934823-49-1 | SDS-PAGE:97.4%;SEC-HPLC:97.7% | 490.00 €~5,347.00 € | Wed 23 Oct 24 |
 | Urelumab REF: 3D-CLA1275CAS: 934823-49-1 | - - - | To inquire | Mon 04 Nov 24 |
Urelumab
CAS:934823-49-1
"Urelumab (BMS-66513), a humanized IgG4 mAb CD137 agonist, boosts T-cell/NK cell-mediated cytotoxicity and anti-tumor activity."
Purity:
SDS-PAGE:97.4%;SEC-HPLC:97.7%
Color and Shape:
Solid
Ref: TM-T77367
| 1mg | 490.00 € | ||
| 5mg | 1,467.00 € | ||
| 10mg | 1,977.00 € | ||
| 25mg | 2,932.00 € | ||
| 50mg | 3,989.00 € | ||
| 100mg | 5,347.00 € |
Estimated delivery in United States, on Wednesday 23 Oct 2024
Ref: 3D-CLA1275
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 4 Nov 2024
